Related Experiment Video

Updated: Mar 13, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K

MicroRNA-203 inhibits tumour growth and metastasis through PDPN

L Wang1,2, Y Mou2, D Meng3

  • 1Department of Otorhinolaryngology, Qilu Hospital of Shandong University, Jinan, Shandong, China.

Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
|October 25, 2016
PubMed
Abstract

Insights

MicroRNA-203 (miR-203) suppresses hypopharyngeal cancer progression by inhibiting podoplanin (PDPN). Lower miR-203 levels correlate with advanced cancer, while its restoration reduces cell viability and metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • MicroRNAs regulate cancer development.
  • miR-203 exhibits anti-tumor properties in various cancers.
  • Its role in hypopharyngeal cancer is not well-defined.

Purpose of the Study:

  • Investigate miR-203 expression in hypopharyngeal cancer.
  • Determine the impact of miR-203 on cancer cell behavior.
  • Elucidate the relationship between miR-203 and podoplanin (PDPN).

Main Methods:

  • Analyzed miR-203 expression in patient tissues and correlated with clinical data.
  • Utilized cell culture and lentiviral transduction to study miR-203 effects.
  • Examined the regulatory interaction between miR-203 and PDPN.

Main Results:

  • miR-203 was downregulated in hypopharyngeal cancer, linked to advanced stages and metastasis.
  • Increased miR-203 inhibited cancer cell viability, migration, and invasion.
  • miR-203 directly targets and suppresses PDPN expression.
  • PDPN silencing mimicked miR-203's inhibitory effects; PDPN overexpression reversed them.

Conclusions:

  • PDPN functions as an oncogene promoting hypopharyngeal cancer.
  • miR-203 acts as a tumor suppressor by targeting PDPN.
  • Restoring miR-203 may offer a therapeutic strategy against hypopharyngeal cancer metastasis.

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

832
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
MicroRNAs01:22

MicroRNAs

12.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K